Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy

Jon A. van Heerden, Ian D Hay, John R. Goellner, Diva Salomao, Janet R. Ebersold, Erik J. Bergstralh, Clive S. Grant

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

Background. The study was designed to determine whether invasion of the tumor capsule, in the absence of vascular invasion (VI), was significant in predicting cause-specific mortality in follicular thyroid carcinoma (FTC). Methods. Seventy-two patients with FTC were treated by us during 1971 through 1985. In 65 cases the tumors could be classified as either showing capsular invasion (CI) alone (20) or VI, with or without CI, (45). Median follow-up of 45 survivors was 11 years; 12 patients died of FTC. Results. The 10-year occurrence rates for cause-specific mortality and distant metastases were 28% and 19%, respectively, for patients with VI. Comparable rates for the patients with CI were 0% (p = 0.019) and 0% (p = 0.052), respectively. By univariate analysis, higher rates of cause-specific mortality were significantly associated with distant metastases at diagnosis (p < 0.0001), the presence of VI (p = 0.019), and moderate or marked microinvasion (p = 0.019). In stepwise multivariate analyses, only distant metastases at diagnosis had independent prognostic significance (p < 0.0001) in the prediction of cause-specific mortality. In a Cox model, adjusting for distant metastases at diagnosis, the presence of VI was of borderline significance (p = 0.06) in predicting cause-specific mortality. Conclusions. FTC, diagnosed on the basis of CI alone, did not result in either distant metastases or cancer-related death. The dominant determinant of cause-specific mortality was the presence of distant metastases at diagnosis.

Original languageEnglish (US)
Pages (from-to)1130-1138
Number of pages9
JournalSurgery
Volume112
Issue number6
StatePublished - 1992

Fingerprint

Follicular Adenocarcinoma
Blood Vessels
Neoplasm Metastasis
Mortality
Neoplasms
Proportional Hazards Models
Capsules
Survivors
Multivariate Analysis

ASJC Scopus subject areas

  • Surgery

Cite this

van Heerden, J. A., Hay, I. D., Goellner, J. R., Salomao, D., Ebersold, J. R., Bergstralh, E. J., & Grant, C. S. (1992). Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy. Surgery, 112(6), 1130-1138.

Follicular thyroid carcinoma with capsular invasion alone : A nonthreatening malignancy. / van Heerden, Jon A.; Hay, Ian D; Goellner, John R.; Salomao, Diva; Ebersold, Janet R.; Bergstralh, Erik J.; Grant, Clive S.

In: Surgery, Vol. 112, No. 6, 1992, p. 1130-1138.

Research output: Contribution to journalArticle

van Heerden, JA, Hay, ID, Goellner, JR, Salomao, D, Ebersold, JR, Bergstralh, EJ & Grant, CS 1992, 'Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy', Surgery, vol. 112, no. 6, pp. 1130-1138.
van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ et al. Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy. Surgery. 1992;112(6):1130-1138.
van Heerden, Jon A. ; Hay, Ian D ; Goellner, John R. ; Salomao, Diva ; Ebersold, Janet R. ; Bergstralh, Erik J. ; Grant, Clive S. / Follicular thyroid carcinoma with capsular invasion alone : A nonthreatening malignancy. In: Surgery. 1992 ; Vol. 112, No. 6. pp. 1130-1138.
@article{186ae31bbb4a42199efb7f933944383e,
title = "Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy",
abstract = "Background. The study was designed to determine whether invasion of the tumor capsule, in the absence of vascular invasion (VI), was significant in predicting cause-specific mortality in follicular thyroid carcinoma (FTC). Methods. Seventy-two patients with FTC were treated by us during 1971 through 1985. In 65 cases the tumors could be classified as either showing capsular invasion (CI) alone (20) or VI, with or without CI, (45). Median follow-up of 45 survivors was 11 years; 12 patients died of FTC. Results. The 10-year occurrence rates for cause-specific mortality and distant metastases were 28{\%} and 19{\%}, respectively, for patients with VI. Comparable rates for the patients with CI were 0{\%} (p = 0.019) and 0{\%} (p = 0.052), respectively. By univariate analysis, higher rates of cause-specific mortality were significantly associated with distant metastases at diagnosis (p < 0.0001), the presence of VI (p = 0.019), and moderate or marked microinvasion (p = 0.019). In stepwise multivariate analyses, only distant metastases at diagnosis had independent prognostic significance (p < 0.0001) in the prediction of cause-specific mortality. In a Cox model, adjusting for distant metastases at diagnosis, the presence of VI was of borderline significance (p = 0.06) in predicting cause-specific mortality. Conclusions. FTC, diagnosed on the basis of CI alone, did not result in either distant metastases or cancer-related death. The dominant determinant of cause-specific mortality was the presence of distant metastases at diagnosis.",
author = "{van Heerden}, {Jon A.} and Hay, {Ian D} and Goellner, {John R.} and Diva Salomao and Ebersold, {Janet R.} and Bergstralh, {Erik J.} and Grant, {Clive S.}",
year = "1992",
language = "English (US)",
volume = "112",
pages = "1130--1138",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Follicular thyroid carcinoma with capsular invasion alone

T2 - A nonthreatening malignancy

AU - van Heerden, Jon A.

AU - Hay, Ian D

AU - Goellner, John R.

AU - Salomao, Diva

AU - Ebersold, Janet R.

AU - Bergstralh, Erik J.

AU - Grant, Clive S.

PY - 1992

Y1 - 1992

N2 - Background. The study was designed to determine whether invasion of the tumor capsule, in the absence of vascular invasion (VI), was significant in predicting cause-specific mortality in follicular thyroid carcinoma (FTC). Methods. Seventy-two patients with FTC were treated by us during 1971 through 1985. In 65 cases the tumors could be classified as either showing capsular invasion (CI) alone (20) or VI, with or without CI, (45). Median follow-up of 45 survivors was 11 years; 12 patients died of FTC. Results. The 10-year occurrence rates for cause-specific mortality and distant metastases were 28% and 19%, respectively, for patients with VI. Comparable rates for the patients with CI were 0% (p = 0.019) and 0% (p = 0.052), respectively. By univariate analysis, higher rates of cause-specific mortality were significantly associated with distant metastases at diagnosis (p < 0.0001), the presence of VI (p = 0.019), and moderate or marked microinvasion (p = 0.019). In stepwise multivariate analyses, only distant metastases at diagnosis had independent prognostic significance (p < 0.0001) in the prediction of cause-specific mortality. In a Cox model, adjusting for distant metastases at diagnosis, the presence of VI was of borderline significance (p = 0.06) in predicting cause-specific mortality. Conclusions. FTC, diagnosed on the basis of CI alone, did not result in either distant metastases or cancer-related death. The dominant determinant of cause-specific mortality was the presence of distant metastases at diagnosis.

AB - Background. The study was designed to determine whether invasion of the tumor capsule, in the absence of vascular invasion (VI), was significant in predicting cause-specific mortality in follicular thyroid carcinoma (FTC). Methods. Seventy-two patients with FTC were treated by us during 1971 through 1985. In 65 cases the tumors could be classified as either showing capsular invasion (CI) alone (20) or VI, with or without CI, (45). Median follow-up of 45 survivors was 11 years; 12 patients died of FTC. Results. The 10-year occurrence rates for cause-specific mortality and distant metastases were 28% and 19%, respectively, for patients with VI. Comparable rates for the patients with CI were 0% (p = 0.019) and 0% (p = 0.052), respectively. By univariate analysis, higher rates of cause-specific mortality were significantly associated with distant metastases at diagnosis (p < 0.0001), the presence of VI (p = 0.019), and moderate or marked microinvasion (p = 0.019). In stepwise multivariate analyses, only distant metastases at diagnosis had independent prognostic significance (p < 0.0001) in the prediction of cause-specific mortality. In a Cox model, adjusting for distant metastases at diagnosis, the presence of VI was of borderline significance (p = 0.06) in predicting cause-specific mortality. Conclusions. FTC, diagnosed on the basis of CI alone, did not result in either distant metastases or cancer-related death. The dominant determinant of cause-specific mortality was the presence of distant metastases at diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0027102237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027102237&partnerID=8YFLogxK

M3 - Article

C2 - 1455315

AN - SCOPUS:0027102237

VL - 112

SP - 1130

EP - 1138

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -